Valproate (Epilim) – Communications

The following communications were distributed to relevant healthcare professionals (general practitioners, general hospital doctors, medical specialists including neurologists, gynaecologists/obstetricians, psychiatrists, pharmacists (both community and hospital), specialist epilepsy nurses and family planning clinics) and patient organisations. They were also published on the HPRA website.


 

Table of communications


2014

Direct Healthcare Professional Communication (DHPC) – December 2014
Drug Safety Newsletter Edition 65 – December 2014

2015

Monthly Index of Medical Specialities (MIMS) Ireland – January 2015

2016

Drug Safety Newsletter Edition 76 – August 2016

Irish Medicines Formulary (IMF) – August 2016
Monthly Index of Medical Specialities (MIMS) Ireland– September 2016

2017

Drug Safety Newsletter Edition 80 – April 2017
Monthly Index of Medical Specialities (MIMS) Ireland – May 2017
Drug Safety Newsletter Edition 81 – July 2017

2018

Drug Safety Newsletter Edition 87 – April 2018
Direct Healthcare Professional Communication for Prescribers - April 2018
Direct Healthcare Professional Communication for Pharmacists - April 2018 

Monthly Index of Medical Specialities (MIMS) Ireland – May 2018
Irish Medicines Formulary (IMF) – August 2018
Monthly Index of Medical Specialities (MIMS) Ireland – October 2018

2019

Monthly Index of Medical Specialities (MIMS) Ireland – April 2019